J&J Says It Will Continue To Make Acquisitions; Med-Tech Biz Shines In Q4
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson says it will continue to invest in acquisitions following yet another strong quarter of medical device sales that salvaged its stagnant pharmaceutical business